Arcutis Biotherapeutics Inc reports results for the quarter ended in September 30 - Earnings Summary

Arcutis Biotherapeutics

06/11/2024 23:19

* Arcutis Biotherapeutics Inc  ARQT.OQ  reported a quarterly
adjusted loss of 33 cents​​ per share for the quarter ended
September 30, higher than the same quarter last year, when the
company reported EPS of -73 cents.  The mean expectation of
seven analysts for the quarter was for a loss of 42 cents per
share. Wall Street expected results to range from -46 cents
to -36 cents per share.
    * Revenue rose 17.4% to $44.76 million from a year ago;
analysts
expected $37.62 million. 
    * Arcutis Biotherapeutics Inc's reported EPS for the quarter
was a
loss of 33 cents​.
    * The company reported a quarterly loss of $41.54 million.
    * Arcutis Biotherapeutics Inc shares had held steady so far
this
quarter and gained 187.9% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 9.5%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Arcutis
Biotherapeutics Inc is 19.00 
This summary was machine generated from LSEG data November 6 at
11:19 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.42          -0.33          Beat
 Jun. 30 2024      -0.52          -0.42          Beat
 Mar. 31 2024      -0.73          -0.32          Beat
 Dec. 31 2023      -0.77          -0.72          Beat